AlphaVest Acquisition Corp. Proxy Supplement Filed

TL;DR

AlphaVest Acquisition Corp. filed a proxy supplement for their Sept 19 meeting. Shareholders need to review.

AI Summary

AlphaVest Acquisition Corp. filed a supplemental proxy statement on September 4, 2025, for an extraordinary general meeting scheduled for September 19, 2025. The filing concerns the company's business and operations, with its principal executive offices located at 420 Lexington Ave, Suite 2446, New York, NY 10170.

Why It Matters

This filing provides updated information to shareholders regarding the upcoming extraordinary general meeting, which is crucial for voting on important corporate matters.

Risk Assessment

Risk Level: low — This is a routine proxy filing providing supplemental information to shareholders, not indicating significant new risks.

Key Players & Entities

• AlphaVest Acquisition Corp. (company) — Registrant
• 420 Lexington Ave, Suite 2446 (location) — Principal Executive Offices
• September 19, 2025 (date) — Extraordinary General Meeting Date
• September 4, 2025 (date) — Filing Date

FAQ

Key Financial Figures

• $5 — ty securities with a price of less than $5.00, other than securities registered on

Filing Documents

• formdefa14a.htm (DEFA14A) — 36KB
• 0001493152-25-012648.txt ( ) — 37KB

From the Filing

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A PROXY SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material under §240.14a-12 ALPHAVEST ACQUISITION CORP. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11 SUPPLEMENT DATED SEPTEMBER 4, 2025 TO PROXY ALPHAVEST ACQUISITION CORP In connection with its EXTRAORDINARY GENERAL MEETING TO BE HELD ON SEPTEMBER 19, 2025 SUPPLEMENT NO. 1, DATED SEPTEMBER 4, 2025 (TO THE DEFINITIVE PROXY STATEMENT OF ALPHAVEST ACQUISITION CORP DATED SEPTEMBER 2, 2025) On September 3, 2025, AlphaVest Acquisition Corp (the “ Company ” or “ AlphaVest ”) filed with the Securities and Exchange Commission a definitive proxy statement (the “ Proxy Statement ”) for its extraordinary general meeting which will be held on September 19, 2025 at 9:30 a.m., Eastern Time (the “ Extraordinary General Meeting ”) at the offices of Winston & Strawn LLP located at 800 Capitol Street, Suite 2400, Houston, Texas, United States, and virtually via live webcast at webcast at www.virtualshareholdermeeting.com/ATMV2025SM2 . SUPPLEMENT TO THE DEFINITIVE PROXY STATEMENT This Supplement, supplements, updates and amends the Definitive Proxy Statement of the Company filed with the Securities and Exchange Commission on September 3, 2025. The following supplemental information should be read in conjunction with the Definitive Proxy Statement, which should be read in its entirety. The sixth risk factor, which begins on page 39, is hereby amended and restated in its entirety as follows: Nasdaq may delist our securities from trading on its exchange, which could limit investors’ ability to make transactions in our securities and subject us to additional trading restrictions. Our units, Ordinary Shares, and rights are currently listed on Nasdaq, a national securities exchange. We cannot assure you that our securities will continue to be listed on Nasdaq in the future prior to an initial business combination, including following any shareholder redemptions in connection with certain amendments to the Articles. If the public shareholders exercise redemption rights with respect to a large number of public shares in connection with the approval of the Extension Proposal and the implementation of the Extension, our securities may no longer meet Nasdaq’s continued listing requirements and Nasdaq may delist our securities from trading on its exchange. Further, pursuant to Nasdaq Rule IM-5101-2, a special purpose acquisition company (“SPAC”) must complete one or more business combinations within 36 months of the effectiveness of the SPAC’s initial public offering. Since the Company’s registration statement became effective on December 22, 2022, it is required to complete its initial business combination by no later than December 22, 2025. Such rule also provides that if the Company does not comply with the above requirement, Nasdaq will issue a Staff Delisting Determination under Rule 5810 to delist the Company’s securities. Accordingly, while the Extension Amendment Proposal provides for extensions up to January 22, 2026, if the Company does not complete its Business Combination by December 22, 2025, the Company will face immediate suspension and delisting of its securities once the Company receives a delisting determination letter from Nasdaq. Pursuant to Nasdaq Rule 5815, as amended, Nasdaq may only reverse its delisting determination if it finds that it made a factual error in applying Nasdaq Rule 5815, as amended. If Nasdaq delists the Company’s securities from trading on its exchange and the Company is not able to list its securities on another national securities exchange, we expect the Company’s securities could be quoted on an over-the-counter market. If this were to occur, we could face significant material adverse consequences, including. a limited availability of market quotations for our securities; reduced liquidity for our securities; reduced demand for our securities; a determination that our Ordinary Shares is a “penny stock” which will require brokers trading in our Ordinary Shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our securities; the Company may be deemed a less attra

View Full Filing

View this DEFA14A filing on SEC EDGAR